CClinicalTrials.gg
CompletedNCT06589076Updated Apr 13, 2026

Apical Periodontitis and Mental Health

An observational study in Apical Periodontitis, Anxiety and Depression, sponsored by University of Siena. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by University of Siena · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

This study is investigating the relationship between anxiety, depression and apical periodontitis (AP), a common oral inflammatory condition. The research is being conducted at the Unit of Endodontic and Conservative Dentistry, University of Siena, Italy, with participants aged over 18. Participants are divided into two groups: those with apical periodontitis and those without. The study aims to determine whether there is an association between anxiety, depression (assessed using the Hamilton Anxiety/Depression Rating Scale), and the presence or severity of apical periodontitis. Data collection includes dental exams, radiographs, and anxiety and depression assessments. This research may help to better understand how mental health and dental health are connected.

Read the detailed description

The aim of the present case-control study is to evaluate the association between apical periodontitis (AP) and mental health conditions, specifically anxiety and depression. Subjects will be enrolled from the Unit of Endodontics and Conservative Dentistry of the University of Siena.

The inclusion criteria of the study are healthy patients older than 18 years, the ability and willingness to give informed consent, and the presence of untreated periapical lesions for the case group. Participants without apical periodontitis will be included in the control group. Participants affected by systemic diseases such as diabetes or rheumatoid arthritis, those using corticosteroid drugs, and those in stage 3 or 4 of periodontitis will be excluded. Additional exclusion criteria include the use of antibiotics within the last 6 months, inability to give informed consent, and pregnancy or lactation.

Seventy-one subjects fulfilling the described criteria will be enrolled and allocated into two distinct groups based on the presence or absence of apical periodontitis. Group 1 will consist of patients with radiographic evidence of AP, and Group 2 will consist of healthy controls free from clinical and radiographic signs of AP. The AP+ group will include patients with at least one tooth showing radiographic evidence of apical radiolucency.

To perform the initial screening, participants will undergo panoramic radiography, clinical examination, and periapical radiographs using the long cone paralleling technique to assess suspected AP. The following parameters will be recorded:

  • The number of decayed, missing, and filled teeth (DMFT index)
  • The number of teeth with apical periodontitis
  • Periapical Index (PAI) Score

All mental health assessments will be conducted using standardized psychiatric scales, including the Hamilton Depression Rating Scale (HAM-D) and the Hamilton Anxiety Rating Scale (HAM-A), to evaluate the severity of depression and anxiety, respectively.

Additionally, smoking status (current, former, or non-smoker) will be recorded to explore its association with apical periodontitis and its potential impact on anxiety and depression scores.

The results expected from this study are:

  • A potential correlation between apical periodontitis and increased anxiety and depression scores (HAM-A and HAM-D).
  • A possible association between smoking habits and the severity of mental health conditions in relation to apical periodontitis.

This study may help to elucidate the connection between oral and mental health, highlighting the importance of holistic health care approaches that consider both physical and psychological factors.

02

Conditions studied

  • Apical Periodontitis
  • Anxiety
  • Depression

Keywords

  • Oral Health
  • Mental Health
  • Apical Periodontitis
  • Anxiety
  • depression
  • smokers
03

In context

Periapical Periodontitis

246 studies on the registry are indexed under Periapical Periodontitis; 64 are open to participants now.

This study's enrollment of 120 is above the median of 72 across 33 observational studies indexed under Periapical Periodontitis.

Browse Periapical Periodontitis studies →

Lead sponsor

University of Siena is the lead sponsor of 65 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants fulfilling the previously described inclusion criteria will be allocated into two distinct groups based on the presence or absence of apical periodontitis (AP). Group 1 will consist of 36 patients showing radiographic signs of apical periodontitis (AP+), while Group 2 will include 35 healthy individuals (AP-) with no clinical or radiographic evidence of AP, serving as controls. Participants in both groups will be matched based on age, sex, and other relevant characteristics. AP cases will be defined as patients with at least one tooth exhibiting radiographic evidence of apical radiolucency, graded using Peri Apical Index (PAI) Score.

Inclusion criteria

  • Ability and willingness to give written consent;
  • Age above 18 years old;
  • Presence of an untreated periapical lesion for the case group;
  • Absence of a periapical lesion for the control group.

Exclusion criteria

Exclusion Criteria:

  • Diabetes;
  • Rheumatoid Arthritis;
  • Use of corticosteroid drugs;
  • Stage 3 and 4 of periodontitis;
  • Inability or unwillingness to give informed consent.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
120 participants (actual)
Patient registry
No

Groups and cohorts

  • Case Group (AP+):

    This group consists of participants who have apical periodontitis (AP), an oral inflammatory condition. These participants are diagnosed with AP based on radiographic evidence. They may exhibit symptoms of AP, but AP is often asymptomatic, so radiographic confirmation is key.

    Diagnostic Test: Clinical and Radiographic assessment + Questionnaires

  • Control Group (AP-):

    This group consists of participants who do not have apical periodontitis (AP). These participants are healthy individuals with no clinical or radiographic signs of apical periodontitis. They will be matched with the case group based on age, gender, and other relevant characteristics, but they will not have any dental lesions related to apical periodontitis.

    Diagnostic Test: Clinical and Radiographic assessment + Questionnaires

Interventions

  • Diagnostic testClinical and Radiographic assessment + Questionnaires

    * Clinical and radiographic examination to assess oral health and apical periodontitis. * Questionnaires to assess Anxiety and depression.

06

What researchers measure

Primary outcomes

  1. Hamilton Anxiety Rating Scale (HAM-A) Score

    The severity of anxiety symptoms is measured using the Hamilton Anxiety Rating Scale (HAM-A). This scale assesses both psychological (mental distress) and somatic (physical symptoms) aspects of anxiety. Scores range from 0 to 56, with higher scores indicating more severe anxiety. The association between HAM-A scores and the presence of apical periodontitis (AP) will be analyzed.

    Time frame: At baseline (during participant enrollment and evaluation)

  2. Hamilton Depression Rating Scale (HAM-D) Score

    The severity of depression is assessed using the 17-item Hamilton Depression Rating Scale (HAM-D). The scale evaluates a range of depressive symptoms such as mood disturbances, guilt, insomnia, anxiety, and somatic concerns. Scores range from 0 to 52, with higher scores indicating more severe depression. The association between HAM-D scores and the presence of apical periodontitis (AP) will be analyzed.

    Time frame: At baseline (during participant enrollment and evaluation)

  3. Periapical Index (PAI) Score

    The Periapical Index (PAI) score is used to assess the severity of apical periodontitis. The score ranges from 1 to 5, with higher scores indicating more severe periapical inflammation. The association between PAI scores and anxiety (HAM-A) and depression (HAM-D) scores will be analyzed.

    Time frame: At baseline (during participant enrollment and evaluation)

Secondary outcomes

  1. Decayed, Missing, and Filled Teeth (DMFT) Index

    The DMFT index is recorded to evaluate the overall dental health of participants. It assesses the number of decayed, missing, and filled teeth, providing a comprehensive measure of oral health. The association between DMFT index and anxiety (HAM-A) and depression (HAM-D) scores will be analyzed.

    Time frame: At baseline (during participant enrollment and evaluation)

  2. Smoking Status and Its Association with Mental Health and Oral Health

    Smoking status (current smoker, former smoker, non-smoker) will be assessed to evaluate its relationship with apical periodontitis and its impact on depression (HAM-D) and anxiety (HAM-A) scores. The analysis will explore whether smoking is a confounding factor in the association between mental health and oral health conditions.

    Time frame: At baseline (during participant enrollment and evaluation)

07

Study locations

1 site
  • Azienda Ospedaliera Universitaria Senese
    Siena, Tuscany 53100, Italy
08

References and documents

Publications

  • Gaeta C, Tavakkoli A, Carmellini P, Cuomo A, Fagiolini A, Grandini S, Malvicini G, Marruganti C. Psychological Assessment of Patients With Apical Periodontitis and Caries: A Case-Control Study. Int Endod J. 2026 Apr 28. doi: 10.1111/iej.70168. Online ahead of print. PubMed 42050649 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06589076
Lead sponsor
University of Siena
Responsible party
Simone Grandini (Professore, University of Siena) — Principal investigator
First posted
Sep 19, 2024
Start date
Apr 1, 2022
Primary completion
Apr 30, 2023
Completion
Apr 30, 2024
Last update
Apr 13, 2026

Study contacts

Simone Grandini, PhD, DDS
principal investigator · University of Siena

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion